Eyestem Research has completed the first set of patient injections for its RPE suspension therapy aimed at treating Dry age-related macular degeneration (AMD).
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.